טוען...
The potential impact of pneumococcal conjugate vaccine in Africa: Considerations and early lessons learned from the South African experience
The introduction of pneumococcal conjugate vaccine (PCV) into the South African public immunization program since 2009 adopted a novel vaccination schedule of 3 doses at 6, 14 and 40 weeks of age. Over the past 5 y it has been shown that infant PCV immunization in South Africa is effective in reduci...
שמור ב:
| הוצא לאור ב: | Hum Vaccin Immunother |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Taylor & Francis
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5049711/ https://ncbi.nlm.nih.gov/pubmed/26317537 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2015.1084450 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|